ICMR study shows COVAXIN neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well
Bharat Biotech and ICMR Announce Interim Results from Phase 3 trials of COVAXIN®; Demonstrates overall Interim Clinical Efficacy of 78% and 100% efficacy against Severe COVID-19 disease
“We understand India’s needs,” says the US Government on vaccine’s raw material supply issues
The US Government responds to Serum’s request for allowing raw material and ingredients for Covid-19 vaccines. Mr Adar Poonawalla, CEO, Serum Institute of India (SII) had requested the US President Biden through a tweet asking the US to lift the embargo of raw material exports out of the US to ramp up vaccine production.
Minister Piyush Goyal launches the Startup India Seed Fund Scheme
Minister says the scheme will Secure seed funding, Inspire innovation, Support transformative ideas, Facilitate implementation, and Start startup revolution. 3,600 startups are expected to benefit from the scheme.